Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. 2002

Anka Thies, and Melitta Schachner, and Ingrid Moll, and Jürgen Berger, and Hans-Joachim Schulze, and Georg Brunner, and Udo Schumacher
Institut für Anatomie, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. thies@uke.uni-hamburg.de

Modulation of cell adhesion molecule expression plays a key role in melanoma metastasis. In particular, the expression of the cell adhesion molecule L1 has been associated with the metastatic phenotype in a murine model of malignant melanoma. However, no such association between L1 expression and metastasis has been investigated in a clinical study. Therefore, L1 expression was determined immunohistochemically in 100 cases of malignant melanoma and correlated with metastasis in a 10-year retrospective study. Furthermore, nine distant metastases and five sentinel lymph node metastases were analysed for their L1 expression. Additionally, the expression of alpha2,3 sialic acid residues, which are recognised by the siglec domain of L1, was determined by Maackia amurensis agglutinin (MAA) lectin histochemistry. The log-rank test between Kaplan-Meier curves revealed a positive association between L1 expression and metastasis (P<0.0001) and multivariate Cox regression analysis adjusted for tumour thickness, ulceration and mitotic rate confirmed the prognostic power of L1 in malignant melanoma. As alpha2,3 sialic acid residues were absent in melanoma cells, homotypic adhesion between melanoma cells via their siglec domain can be excluded, suggesting a different adhesive function of L1 during melanoma metastasis. The functional role of L1 was further stressed by the fact that its expression was preserved in metastatic lesions.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Anka Thies, and Melitta Schachner, and Ingrid Moll, and Jürgen Berger, and Hans-Joachim Schulze, and Georg Brunner, and Udo Schumacher
September 1993, Clinical & experimental metastasis,
Anka Thies, and Melitta Schachner, and Ingrid Moll, and Jürgen Berger, and Hans-Joachim Schulze, and Georg Brunner, and Udo Schumacher
March 2001, British journal of cancer,
Anka Thies, and Melitta Schachner, and Ingrid Moll, and Jürgen Berger, and Hans-Joachim Schulze, and Georg Brunner, and Udo Schumacher
January 2003, Cancer letters,
Anka Thies, and Melitta Schachner, and Ingrid Moll, and Jürgen Berger, and Hans-Joachim Schulze, and Georg Brunner, and Udo Schumacher
December 2014, Human pathology,
Anka Thies, and Melitta Schachner, and Ingrid Moll, and Jürgen Berger, and Hans-Joachim Schulze, and Georg Brunner, and Udo Schumacher
February 2005, Clinical cancer research : an official journal of the American Association for Cancer Research,
Anka Thies, and Melitta Schachner, and Ingrid Moll, and Jürgen Berger, and Hans-Joachim Schulze, and Georg Brunner, and Udo Schumacher
November 2008, European journal of medical research,
Anka Thies, and Melitta Schachner, and Ingrid Moll, and Jürgen Berger, and Hans-Joachim Schulze, and Georg Brunner, and Udo Schumacher
August 2006, International journal of cancer,
Anka Thies, and Melitta Schachner, and Ingrid Moll, and Jürgen Berger, and Hans-Joachim Schulze, and Georg Brunner, and Udo Schumacher
November 2002, Laboratory investigation; a journal of technical methods and pathology,
Anka Thies, and Melitta Schachner, and Ingrid Moll, and Jürgen Berger, and Hans-Joachim Schulze, and Georg Brunner, and Udo Schumacher
August 2020, European journal of dermatology : EJD,
Anka Thies, and Melitta Schachner, and Ingrid Moll, and Jürgen Berger, and Hans-Joachim Schulze, and Georg Brunner, and Udo Schumacher
September 2016, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!